Plan Name [Axis]
2015 Long-term Incentive Plan [Member]
Income Statement Location [Axis]
General and Administrative Expense [Member]
Exercise Price Range [Axis]
Exercise Price 0.55 [Member]
Exercise Price 2.00-3.85 [Member]
Exercise Price 5.10-7.20 [Member]
Exercise Price 0.55-7.20 [Member]
Type of Arrangement and Non-arrangement Transactions [Axis]
Exclusive License Agreement [Member]
Title of Individual [Axis]
Dr. Brent Satterfield [Member]
Debt Instrument [Axis]
Robert Salna Promissory Note [Member]
Long-term Debt, Type [Axis]
Unsecured Debt [Member]
Award Type [Axis]
CAD [Member]
Nine Employees [Member]
Three Members Our Board of Directors [Member]
Equity Components [Axis]
Warrant [Member]
Award Date [Axis]
2019 [Member]
2020 [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings (Deficit) [Member]
Joint Venture Agreement [Member]
Underwriting Agreement [Member]
Legal Entity [Axis]
WallachBeth Capital, LLC [Member]
Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]
Up to $1,000,000 [Member]
$1,000,000-$2,000,000 [Member]
$2,000,000-$3,000,000 [Member]
Above $3,000,000 [Member]
Financial Instrument [Axis]
Robert Salna Promissory Note Payable [Member]
Market Licensing Agreement [Member]
Sales and Marketing [Member]
Dr. Satterfield [Member]
Range [Axis]
Maximum [Member]
Related Party [Axis]
Two Companies [Member]
Six Individuals and Four Companies [Member]
Four Companies [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Class of Stock [Axis]
Series A Convertible Preferred Stock [Member]
Investor [Member]
Ownership [Axis]
Beneficial Ownership [Member]
Series A Preferred Stock [Member]
Document And Entity Information
Entity Registrant Name
Entity Central Index Key
Document Type
Document Period End Date
Amendment Flag
Current Fiscal Year End Date
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Filer Category
Entity Small Business Flag
Entity Emerging Growth Company
Entity Ex Transition Period
Entity Shell Company
Entity Public Float
Entity Common Stock, Shares Outstanding
Trading Symbol
Document Fiscal Period Focus
Document Fiscal Year Focus
Statement of Financial Position [Abstract]
ASSETS:
Current Assets
Cash and cash equivalents
Accounts receivable ,net
Inventory
Prepaid expenses
Total current assets
Property and equipment, net
Investment in joint venture
Total other long-term assets
Total assets
LIABILITIES AND STOCKHOLER'S EQUITY (DEFICIT):
Current Liabilities
Accounts payable
Accrued expenses
Accrued expenses (related party)
Current notes payable net of $91,428 and $0 discount, respectively
Deferred income current
Total current liabilities
Long-term Liabilities
Accrued liabilities (related-party)
Deferred income long-term
Total long-term liabilities
Total liabilities
Commitments and contingencies
STOCKHOLDERS' EQUITY (DEFICIT):
Common stock, $.001 par value, 100,000,000 shares authorized; 12,923,383 and 12,317,184 shares issued and outstanding, respectively.
Preferred stock, $.001 par value, 5,000,000 shares authorized
Additional paid-in capital
Accumulated deficit
Total stockholders' equity (deficit)
Total liabilities and stockholders' equity (deficit)
Current notes payable related party, discount
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Preferred stock, par value
Preferred stock, shares authorized
Income Statement [Abstract]
Net sales
Cost of sales
Gross profit
Operating expenses:
Selling and marketing
Administrative and general
Research and development
Depreciation and amortization
Total operating expenses
Total operating loss
Other expense:
Interest expense
Interest income
Loss on extinguishment of debt
Net loss from investment in joint venture
Total other expense
Loss before income taxes
Provision for income taxes
Net loss
Net loss per share - basic and diluted
Weighted average shares - basic and diluted
Statement [Table]
Statement [Line Items]
Beginning balance
Beginning balance, shares
Stock issued for cash, net of offering costs of $1,093,268
Stock issued for cash, net of offering costs of $1,093,268, shares
Stock issued for debt retirement
Stock issued for debt retirement, shares
Stock-based compensation
Stock-based compensation, shares
Stock issued for exercise of warrants
Stock issued for exercise of warrants, shares
Net loss
Ending balance
Ending balance, shares
Statement of Stockholders' Equity [Abstract]
Stock offering cost
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation
Accretion of notes payable discount
Loss on extinguishment of debt
Other losses
Changes in assets and liabilities:
Increase (decrease) deferred income
Decrease (increase) in prepaid and other assets
Increase in accounts receivable
Increase in inventory
Increase in accounts payable and accrued expenses
Net cash used in operating activities
Cash flows from investing activities:
Purchase of property and equipment
Investment in joint venture
Net cash used by investing activities
Cash flows from financing activities:
Proceeds from equity financing
Offering costs from equity financing
Proceeds from warrant exercise
Proceeds from debt financing
Debt financing acquisition costs
Principal payments on debt (related party)
Net cash provided by financing activities
Net increase (decrease) in cash
Cash and cash equivalents beginning of period
Cash and cash equivalents end of period
Supplemental disclosure of cash flow information:
Interest paid
Income taxes paid
Schedule of non-cash (investing) and financing activities:
Common stock issued for convertible debt
Accounting Policies [Abstract]
Organization and Summary of Significant Accounting Policies
Debt Disclosure [Abstract]
Notes Payable
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation
Insurance [Abstract]
Lease Obligations
Related Party Transactions [Abstract]
Related Party Transactions
Equity [Abstract]
Equity
Income Tax Disclosure [Abstract]
Income Taxes
Subsequent Events [Abstract]
Subsequent Events
Cash and Cash Equivalents
Inventory
Accounts Receivable
Property and Equipment
Equity-Method Investments
Earnings (Loss) Per Share
Stock-based Compensation
Income Taxes
Research and Development
Use of Estimates
Fair Value Measurements
Patents and Intangibles
Long-Lived Assets
Customer Leased Equipment
Revenue Recognition
Related-Party Transactions
Recently Issued Accounting Standards
Schedule of Profits from Joint Venture
Schedule of Notes Payable
Schedule of Fair Values Options Weighted Average Assumptions
Summary of Option Activity
Schedule of Fair Values Warrants Assumptions
Summary of Warrant Activity
Summary of Stock Option and Warrant Outstanding
Schedule of Unrecognized Stock-based Compensation
Schedule of Lease Rent Obligations
Schedule of Deferred Tax Assets
Schedule of Income Tax Provision
Investment in joint venture
Interest rate
Reimbursement expenses
Reverse stock split
Initial public offering, shares
Common stock, price per share
Commissions and non-accountable expense allowance, par value
Exercisable period
Additional shares of common stock to cover over-allotments
Proceeds from issuance of initial public offering
Net proceeds from initial public offering
Debt principal amount
Accrued interest
Number of common stock issued
Cash in excess of federal deposit insurance corporation
Short-term deposits
Potentially dilutive shares
Research and development cost
Patents and intangibles useful life
Leased equipment description
CDI Share
Partner Share
Current notes payable, discount
Debt interest rate
Debt maturity date
Note repayable
Debt principal payments
Interest expense
Debt note origination cost
Interest expense for accretion
Notes payable
Total
Less Current Portion
Total Long-term
Aggregate number of common shares reserved
Unissued common stock options authorized shares
Number of options granted
Weighted average fair value of options granted
Stock-based compensation expense related to granted
Options granted, value
Options vesting amount
Warrants issued
Weighted average fair value, warrant issued
Number of common stock issued
Exercise of warrants outstanding, shares
Exercise of warrants outstanding
Stock issued for consulting services, shares
Stock issued for consulting services
Stock repurchased during period, shares
Stock repurchased during period, value
Unrecognized stock-based compensation
Risk free interest rate
Expected life (in years)
Expected volatility
Expected dividend yield
Stock price
Options Outstanding, Beginning
Options Outstanding, Option granted
Options Outstanding, Expired
Options Outstanding, Forfeited options
Options Outstanding, Exercised
Options Outstanding, Ending
Weighted Average Exercise Price Outstanding, Beginning
Weighted Average Exercise Price Options granted
Weighted Average Exercise Price Expired
Weighted Average Exercise Price Forfeited options
Weighted Average Exercise Price Exercised
Weighted Average Exercise Price Outstanding, Ending
Weighted Average Fair Value Outstanding, Beginning
Weighted Average Fair Value Options granted
Weighted Average Fair Value Expired
Weighted Average Fair Value Forfeited options
Weighted Average Fair Value Exercised
Weighted Average Fair Value Outstanding, Ending
Weighted-average Remaining Contractual Life (years) Outstanding, Beginning
Weighted-average Remaining Contractual Life (years) Options granted
Weighted-average Remaining Contractual Life (years) Outstanding, Ending
Warrant Outstanding, Beginning
Warrant Outstanding, Warrants issued
Warrant Outstanding, Expired
Warrant Outstanding, Forfeited warrants
Warrant Outstanding, Exercised
Warrant Outstanding, Ending
Weighted Average Exercise Price, Beginning
Weighted Average Exercise Price, Warrant issued
Weighted Average Exercise Price, Expired
Weighted Average Exercise Price, Forfeited warrants
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Ending
Weighted Average Fair Value, Beginning
Weighted Average Fair Value, Warrant issued
Weighted Average Fair Value, Expired
Weighted Average Fair Value, Forfeited warrants
Weighted Average Fair Value, Exercised
Weighted Average Fair Value, Ending
Weighted-average Remaining Contractual Life (Years), Beginning
Weighted-average Remaining Contractual Life (Years), Warrants issued
Weighted-average Remaining Contractual Life (Years), Exercised
Weighted-average Remaining Contractual Life (Years), Ending
Range of Exercise Prices
Range of Exercise Prices
Number outstanding
Weighted average remaining contractual life
Weighted average exercise price
Number exercisable
Weighted average exercise price exercisable
Total
Area of land
Contract lease per month
Lease expiration date
Rent expenses
2019
2020
Total
Royalty payments, per month
Equity funding
Increase in Royalties Payable, per month
Accrued royalties
Research and development expense
Due to related party
Warrants to purchase of common stock
Warrants exercisable price per share
Aggregate value
Number of warrants exercised
Stock issued for services, shares
Actual number of stock authorized to issue
Conversion of debt
Agency fees
Sales of equity common stock
Net operating loss carry-forwards
Operating loss carry-forwards period
Penalties or interest incurred
NOL carry-forward
Sec 179 carry-forwards
Depreciation
Valuation allowance
Net deferred tax asset
Book loss
Depreciation
Meals and entertainment
Other non-deductible expenses
Change in valuation allowance
Income tax provision
Number of common stock issued, value
Purchase price paid
Convertible note payable related parties
Equity ownership percentage
Sales of common stock price per shares
Issuance of common stock gross proceeds
Conversion of common stock converted
Conversion of stock, amount converted
Stock conversion price per share
Exclusive License Agreement [Member]
0.11-0.55 [Member]
2.00-3.85 [Member]
0.11-7.20 [Member]
5.10-7.20 [Member]
Summary of Stock Option and Warrant Outstanding [Table Text Block]
2015 Long-term Incentive Plan [Member]
Options [Member]
Warrants [Member]
Outstanding Options [Member]
Outstanding Warrants [Member]
Schedule of Fair Values Warrants Assumptions [Table Text Block]
CAD [Member]
Nine Employees [Member]
Options granted, value.
Three Independent Members [Member]
Three Members Our Board of Directors [Member]
Options vesting amount.
The number of equity-based payment instruments, excluding stock (or unit) options, that were Expired during the reporting period.
The number of equity-based payment instruments, excluding stock (or unit) options, that were Exercised during the reporting period.
Weighted average grant-date fair value of non-vested other than options outstanding.
Share based compensation arrangement by share based payment award equity instruments other than options weighted average grant,
Share based compensation arrangement by share based payment award equity instruments other than options weighted average Expired.
Share based compensation arrangement by share based payment award equity instruments other than options weighted average forfeited.
Share based compensation arrangement by share based payment award equity instruments other than options weighted average exercised.
Share based compensation arrangement by share based payment award equity instruments other than options expired weighted average grant date fair value.
Share based compensation arrangement by share based payment award equity instruments other than options exercised weighted average grant date fair value.
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible.
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
2018 [Member]
2019 [Member]
2020 [Member]
DNA Logix-Canada [Member]
Share based compensation arrangement by share based payment award equity instruments other than options exercised weighted average grant date fair value.
Dr. Brent Satterfield [Member]
Stock issued for debt retirement.
Stock issued for debt retirement, shares.
Customer Leased Equipment [Policy Text Block]
Related-Party Transactions [Policy Text Block]
Joint Venture Agreement [Member]
Commissions and non-accountable expense allowance, par value.
Underwriting Agreement [Member]
WallachBeth Capital, LLC [Member]
Net proceeds from initial public offering.
Up to $1,000,000 [Member]
$1,000,000-$2,000,000 [Member]
$2,000,000-$3,000,000 [Member]
Above $3,000,000 [Member]
CDI share.
Partner share.
Convertible Promissory Note [Member]
Stock issued for exercise of warrants.
Stock issued for exercise of warrants, shares.
Leased equipment description.
Robert Salna Promissory Note [Member]
Robert Salna Promissory Note Payable [Member]
Market Licensing Agreement [Member]
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible.
Exercise of warrants outstanding.
Exercise of warrants outstanding, shares.
Dr. Satterfield [Member]
Equity funding.
This element represent warrants to purchase of common stock.
Two Companies [Member]
Six Individuals and Four Companies [Member]
Agency fees.
Four Companies [Member]
Operating loss carry-forwards period.
Deferred tax asset depreciation.
Penalties or interest incurred.
Actual number of stock authorized to issue.
Series A Convertible Preferred Stock [Member]
Beneficial Ownership [Member]
Interest expense for accretion.
Sales and Marketing [Member]
Weighted-average Remaining Contractual Life (years) Options granted.
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Purchase price paid.
Stock conversion price per share.
Assets, Current
Assets, Noncurrent
Assets
Liabilities, Current
Liabilities, Noncurrent
Liabilities
Stockholders' Equity Attributable to Parent
Liabilities and Equity
Gross Profit
Operating Expenses
Operating Income (Loss)
Interest Expense, Other
Other Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Shares, Outstanding
Increase (Decrease) in Deferred Income Taxes
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Inventories
Net Cash Provided by (Used in) Operating Activities
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Interest in Joint Venture
Net Cash Provided by (Used in) Investing Activities
Payments of Debt Restructuring Costs
Payment of Financing and Stock Issuance Costs
Net Cash Provided by (Used in) Financing Activities
Cash and Cash Equivalents, Period Increase (Decrease)
Inventory, Policy [Policy Text Block]
Income Tax, Policy [Policy Text Block]
Long-term Debt, Excluding Current Maturities
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
0.11-7.20 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized
Operating Leases, Future Minimum Payments Due
Deferred Tax Assets, Valuation Allowance
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Depreciation, Amount